U-Blot® Research Grade ZamerovimabCat. No. WA3820Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade ZamerovimabCat. No. WA3820U-Blot® Research Grade ZalutumumabCat. No. WA3819Request quote
Size: 50ug/100ug
U-Blot® Research Grade ZaltenibartCat. No. WA3818Request quote
Size: 50ug/100ug
U-Blot® Research Grade ZalifrelimabCat. No. WA3817Request quote
Size: 50ug/100ug
U-Blot® Research Grade ZalferminCat. No. WA3816Request quote
Size: 50ug/100ug
U-Blot® Research Grade ZagotenemabCat. No. WA3815Request quote
Size: 50ug/100ug
U-Blot® Research Grade zafinofusp alfaCat. No. WA3814Request quote
Size: 50ug/100ug
U-Blot® Research Grade zadoprubartCat. No. WA3813Request quote
Size: 50ug/100ug
U-Blot® Research Grade XMT-1660Cat. No. WA3812Request quote
Size: 50ug/100ug
U-Blot® Research Grade XirestomigCat. No. WA3811Request quote
Size: 50ug/100ug
U-Blot® Research Grade XentuzumabCat. No. WA3810Request quote
Size: 50ug/100ug
U-Blot® Research Grade XeligekimabCat. No. WA3809Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
FAX+(1)-866-986-9598